BG42189A3 - Method for preparing of ripe human leucocytic interferon - Google Patents

Method for preparing of ripe human leucocytic interferon

Info

Publication number
BG42189A3
BG42189A3 BG8152673A BG5267381A BG42189A3 BG 42189 A3 BG42189 A3 BG 42189A3 BG 8152673 A BG8152673 A BG 8152673A BG 5267381 A BG5267381 A BG 5267381A BG 42189 A3 BG42189 A3 BG 42189A3
Authority
BG
Bulgaria
Prior art keywords
interferon
preparing
ripe human
human leucocytic
leucocytic
Prior art date
Application number
BG8152673A
Other languages
English (en)
Inventor
Norman
Pestka
Original Assignee
Hoffman- La Roche & Co Ag (F.),Ch
Genentech Inc,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27496622&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG42189(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/256,204 external-priority patent/US6610830B1/en
Application filed by Hoffman- La Roche & Co Ag (F.),Ch, Genentech Inc,Us filed Critical Hoffman- La Roche & Co Ag (F.),Ch
Publication of BG42189A3 publication Critical patent/BG42189A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BG8152673A 1980-07-01 1981-06-29 Method for preparing of ripe human leucocytic interferon BG42189A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16498680A 1980-07-01 1980-07-01
US18490980A 1980-09-08 1980-09-08
US20557880A 1980-11-10 1980-11-10
US06/256,204 US6610830B1 (en) 1980-07-01 1981-04-21 Microbial production of mature human leukocyte interferons

Publications (1)

Publication Number Publication Date
BG42189A3 true BG42189A3 (en) 1987-10-15

Family

ID=27496622

Family Applications (1)

Application Number Title Priority Date Filing Date
BG8152673A BG42189A3 (en) 1980-07-01 1981-06-29 Method for preparing of ripe human leucocytic interferon

Country Status (36)

Country Link
EP (2) EP0043980B1 (fi)
AR (1) AR242833A1 (fi)
AT (3) ATE29727T1 (fi)
AU (1) AU552004B2 (fi)
BG (1) BG42189A3 (fi)
BR (1) BR8104189A (fi)
CH (2) CH657141A5 (fi)
CS (1) CS273152B2 (fi)
DD (3) DD210304A5 (fi)
DE (3) DE3177288T3 (fi)
DK (1) DK173543B1 (fi)
DZ (1) DZ312A1 (fi)
ES (1) ES8207514A1 (fi)
FI (1) FI82712C (fi)
FR (1) FR2486098B1 (fi)
GB (1) GB2079291B (fi)
GE (1) GEP19960519B (fi)
GR (1) GR75714B (fi)
HK (1) HK49285A (fi)
HU (1) HU196457B (fi)
IE (1) IE49255B1 (fi)
IT (1) IT1137272B (fi)
KE (1) KE3534A (fi)
LU (1) LU83461A1 (fi)
MC (1) MC1396A1 (fi)
MY (1) MY8700711A (fi)
NL (1) NL8103151A (fi)
NO (1) NO159392C (fi)
NZ (1) NZ197572A (fi)
PH (1) PH18036A (fi)
PL (3) PL148260B1 (fi)
PT (1) PT73289B (fi)
RO (1) RO87590A (fi)
SE (2) SE8104093L (fi)
SU (1) SU1414319A3 (fi)
YU (1) YU47700B (fi)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
IL62552A0 (en) 1980-04-03 1981-06-29 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides
ATE25985T1 (de) * 1980-06-12 1987-04-15 Japan Found Cancer Plasmid.
DK489481A (da) * 1980-11-10 1982-05-11 Searle & Co Plasmidvektor og frmgangsmaade til fremstilling deraf
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
JPS58501543A (ja) * 1981-08-14 1983-09-16 エイ／エス　アルフレツド　ベンツオン ヒトインタ−フエロン蛋白とヒトインタ−フエロン蛋白に対する抗体に関する改良
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US5098703A (en) * 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76
US4975276A (en) * 1982-01-15 1990-12-04 Cetus Corporation Interferon-alpha 54
US4973479A (en) * 1982-01-15 1990-11-27 Cetus Corporation Interferon-α61
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
EP0088994B1 (en) * 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
CA1210714A (en) * 1982-03-23 1986-09-02 Alan Sloma .alpha.-INTERFERON GX-1
US4748233A (en) * 1982-03-23 1988-05-31 Bristol-Myers Company Alpha-interferon Gx-1
US4695543A (en) * 1982-03-23 1987-09-22 Bristol-Myers Company Alpha Interferon GX-1
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4751287A (en) * 1983-02-24 1988-06-14 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr Human leukocyte interferon N and a method of producing same in bacterial cells
EP0165942A1 (en) * 1983-12-23 1986-01-02 Monash University PRODUCTION OF HUMAN INTERFERON-$g(a)
SU1364343A1 (ru) * 1984-07-13 1988-01-07 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Способ получени человеческого лейкоцитарного интерферона альфа-2
WO1986002068A1 (en) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Mutual separation of proteins
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
JP2514950B2 (ja) * 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質，その製造法および中間体
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
CA1309044C (en) * 1987-11-09 1992-10-20 Toshiya Takano Method of producing foreign gene products
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
WO1991003251A1 (en) * 1989-09-08 1991-03-21 California Institute Of Biological Research Cr2 ligand compositions and methods for modulating immune cell functions
DE3932311A1 (de) * 1989-09-28 1991-04-11 Boehringer Ingelheim Int Verfahren zur reinigung von beta-interferon
ATE227133T1 (de) * 1994-03-07 2002-11-15 Imperial College Verwendung von interferon-alpha 8 subtype zur herstellung von medikamenten zur behandlung von viralinfektionen der leber
ES2161793T3 (es) * 1994-04-09 2001-12-16 Hoffmann La Roche Proceso para la produccion de alfa-interferona.
GB9609932D0 (en) * 1996-05-13 1996-07-17 Hoffmann La Roche Use of IL-12 and IFN alpha for the treatment of infectious diseases
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
AU761577C (en) 1997-12-08 2004-02-05 Genentech Inc. Human interferon-epsilon: a type I interferon
CN1264575C (zh) 1998-08-06 2006-07-19 山景药品公司 聚乙二醇或聚环氧乙烷－尿酸氧化酶结合物及其应用
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
JP2004537964A (ja) * 2000-11-03 2004-12-24 ペストカ バイオメディカル ラボラトリーズ インコーポレイテッド インターフェロン、それに関する使用及び組成物
FR2822845B1 (fr) 2001-03-30 2003-12-12 Genodyssee Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
KR20080009111A (ko) 2005-04-11 2008-01-24 새비언트 파마수티컬즈 인크. 유레이트 옥시다아제의 변이형 및 이의 용도
EP2245044A2 (en) * 2008-01-18 2010-11-03 F. Hoffmann-La Roche AG Purification of non-glycosylated proteins
PL398781A1 (pl) 2009-06-25 2012-11-19 Savient Pharmaceuticals, Inc. Sposoby i zestawy do prognozowania ryzyka wystapienia reakcji na wlew oraz zaniku odpowiedzi której posrednicza przeciwciala poprzez monitorowanie kwasu moczowego w surowicy podczas terapii z zastosowaniem pegylowanej urykazy
WO2018087345A1 (en) 2016-11-14 2018-05-17 F. Hoffmann-La Roche Ag COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (fi) * 1978-11-24 1982-12-04 Hoffmann La Roche
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
DK170236B1 (da) * 1980-01-08 1995-07-10 Biogen Inc Rekombinante DNA-molekyler, fremgangsmåde til fremstilling af et polypeptid af IFN-alfa typen og fremgangsmåde til udvælgelse af DNA-sekvenser, der koder for polypeptider af IFN-alfa typen
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
ATE25985T1 (de) * 1980-06-12 1987-04-15 Japan Found Cancer Plasmid.
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
EP0062971B1 (en) * 1981-03-27 1990-03-07 Imperial Chemical Industries Plc Genetically modified microorganisms

Also Published As

Publication number Publication date
MY8700711A (en) 1987-12-31
PL231940A1 (en) 1983-07-18
IE811463L (en) 1982-01-01
EP0043980A3 (en) 1982-09-15
KE3534A (en) 1985-06-07
IT8122682A0 (it) 1981-07-01
SE465223B (sv) 1991-08-12
EP0211148B2 (en) 1999-11-24
PT73289A (en) 1981-07-01
GB2079291A (en) 1982-01-20
RO87590A (ro) 1986-07-30
PH18036A (en) 1985-03-06
AR242833A1 (es) 1993-05-31
ES503528A0 (es) 1982-10-01
DE3125706C2 (de) 1995-05-24
IE49255B1 (en) 1985-09-04
ATE79901T1 (de) 1992-09-15
EP0211148B1 (en) 1992-08-26
YU47700B (sh) 1996-01-08
EP0043980A2 (en) 1982-01-20
PL148276B1 (en) 1989-09-30
ATE29727T1 (de) 1987-10-15
NL8103151A (nl) 1982-02-01
FR2486098B1 (fr) 1985-12-27
FI812067L (fi) 1982-01-02
PT73289B (en) 1983-05-11
NZ197572A (en) 1985-07-31
MC1396A1 (fr) 1982-04-27
AU7246281A (en) 1982-01-07
FR2486098A1 (fr) 1982-01-08
PL148260B1 (en) 1989-09-30
CS503781A2 (en) 1990-07-12
EP0043980B1 (en) 1987-09-16
IT1137272B (it) 1986-09-03
HU196457B (en) 1988-11-28
NO159392B (no) 1988-09-12
DK291081A (da) 1982-01-02
AU552004B2 (en) 1986-05-22
NO159392C (no) 1988-12-21
HK49285A (en) 1985-07-05
SE8104093L (sv) 1982-01-02
PL148261B1 (en) 1989-09-30
DD210304A5 (de) 1984-06-06
ATA290981A (de) 1985-09-15
DE3125706A1 (de) 1982-04-15
DE3177288D1 (de) 1992-10-01
DE3176448D1 (en) 1987-10-22
DZ312A1 (fr) 2004-09-13
AT380272B (de) 1986-05-12
DE3177288T2 (de) 1992-12-10
GR75714B (fi) 1984-08-02
DE3177288T3 (de) 2000-03-16
NO812247L (no) 1982-01-04
SE465223C5 (sv) 1998-02-10
FI82712B (fi) 1990-12-31
GB2079291B (en) 1984-06-13
FI82712C (fi) 1991-04-10
YU162281A (en) 1984-02-29
ES8207514A1 (es) 1982-10-01
DD202307A5 (de) 1983-09-07
GEP19960519B (en) 1996-07-02
SU1414319A3 (ru) 1988-07-30
LU83461A1 (de) 1983-04-06
DD210305A5 (de) 1984-06-06
CH657141A5 (de) 1986-08-15
CS273152B2 (en) 1991-03-12
EP0211148A1 (en) 1987-02-25
BR8104189A (pt) 1982-03-16
DK173543B1 (da) 2001-02-05
CH651308A5 (de) 1985-09-13

Similar Documents

Publication Publication Date Title
BG42189A3 (en) Method for preparing of ripe human leucocytic interferon
DE3164030D1 (en) Non gathering panty and method of manufacture thereof
ZW14781A1 (en) Interferons and process for their preparation
EG15446A (en) Method of preparation 2-amino-3-cabethoxyamino-6-(fluro-benzylamino)-pyridine-maleate
BG49616A3 (en) Method for preparing of betain
GB2075972B (en) Method of synthesizing-unsaturatedketones
IL62073A (en) Shaped short knickers and method of manufacturing
GB2090566B (en) Method of bonding
EG16472A (en) Method of preparing 3-phenoxy-1-azetidinecarboxamides
BG46981A1 (en) Method for preparing of human leucocytaric alpha- 2- interferon
MW2581A1 (en) Interferons and process for their preparation
BG44208A3 (en) Method for preparation of enduracydine
JPS56113559A (en) Method of preserving broiled eel
BG35895A3 (en) Method for preparing of n- substituted- 2- haloacetanilides
JPS56163952A (en) Method of adjusting clearance in servo-booster
DE3163003D1 (en) Method of obtaining factor viii
JPS56167320A (en) Method of trimming composite part
JPS56134488A (en) Method of solderlessly bonding
JPS5763802A (en) Method of producing thick varistor
JPS56132731A (en) Lead switch and method of producing same
JPS56169390A (en) Method of connecting wire
JPS5774447A (en) Connecting method of parts
DE3067941D1 (en) Method for preparing aminoalkyl esters of aminoacids
JPS5759302A (en) Method of producing slide
JPS56153667A (en) Method of connecting wire